The association of polytherapy and psychiatric comorbidity in epilepsy.

Journal: Epilepsy & behavior : E&B

Volume: 163

Issue: 

Year of Publication: 

Affiliated Institutions:  Neurosciences Unit, KEMRI Wellcome Trust Research Programme, P.O. Box -, Kilifi, Kenya; The Open University, P.O. Box , Milton Keynes, MK BJ, United Kingdom. Neurosciences Unit, KEMRI Wellcome Trust Research Programme, P.O. Box -, Kilifi, Kenya. UCL Queen Square Institute of Neurology, London WCN BG and Chalfont Centre for Epilepsy, Chalfont St Peter, SL RJ, United Kingdom. UCL Queen Square Institute of Neurology, London WCN BG and Chalfont Centre for Epilepsy, Chalfont St Peter, SL RJ, United Kingdom; Department of Neurology, West China Hospital, Sichuan University, Chengdu , China. Neurosciences Unit, KEMRI Wellcome Trust Research Programme, P.O. Box -, Kilifi, Kenya; Department of Public Health, School of Human and Health Sciences, Pwani University, P.O Box -, Kilifi, Kenya; Department of Psychiatry, University of Oxford, Oxford, United Kingdom. Neurosciences Unit, KEMRI Wellcome Trust Research Programme, P.O. Box -, Kilifi, Kenya; Department of Public Health, School of Human and Health Sciences, Pwani University, P.O Box -, Kilifi, Kenya; Department of Psychiatry, University of Oxford, Oxford, United Kingdom; African Population and Health Research Centre, Nairobi, Kenya. Electronic address: skariuki@kemri-wellcome.org.

Abstract summary 

Managing epilepsy may require using more than one anti-seizure medication (ASM). While combination therapy may help, risks, including psychiatric problems, are not fully explored in Africa. We examined the relationship between polytherapy and psychiatric comorbidities among attendees of an epilepsy community clinic.We prospectively assessed individuals attending an outpatient clinic in Kilifi, Kenya, for patterns of ASM prescribing (mono- or polytherapy) and reviewed psychiatric diagnoses. We used the Psychosis Screening Questionnaire and the Patient Health Questionnaire Version 9 to assess for psychosis and depression, and the Child Behavior Checklist to assess for emotional and behavioural problems. We conducted a cross-sectional logistic regression analysis to determine factors associated with polytherapy and examine the impact of polytherapy and specific medication on psychiatric comorbidities.Of 3,016 attendees, most were on older ASM (99.7 %), with about a third (32.9 %) on polytherapy. The most commonly co-administered drugs were phenobarbital and carbamazepine (13.0 %). Children were less likely to be on multiple medications than adults, and there was no difference between the sexes. Polytherapy was associated with focal to bilateralised seizures (aOR 1.2 [95 % confidence interval:1.0-1.4]) and frequent seizures (aOR = 2.1 [1.5-2.9]). Combining drugs increased the likelihood of any psychiatric problems (aOR = 1.3 [1.0-1.8]), with polytherapy associated with depression (aOR = 2.9 [1.0-8.4]) and psychosis (aOR = 1.9 (1.0-3.6)).Polytherapy, especially with older drugs, is associated with psychiatric comorbidities in this population. Resorting to polytherapy needs to be carefully considered. Prioritizing research into the long-term effects of ASM on psychiatric comorbidities is crucial for improving mental health outcomes in epilepsy, particularly in low-income settings.

Authors & Co-authors:  Odhiambo Mercy A MA Kaingu Gilbert K GK Mumbo Maria M Kipper Karin K Sander Josemir W JW R J C Newton Charles C Kariuki Symon M SM

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  8
Identifiers
Doi : 10.1016/j.yebeh.2024.110215
SSN : 1525-5069
Study Population
Male,Female
Mesh Terms
Other Terms
Africa;Anti-seizure medications;Community epilepsy clinic;Mental health problems;Polytherapy
Study Design
Cross Sectional Study
Study Approach
Country of Study
Kenya
Publication Country
United States